These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2798918)

  • 1. [Regulation of cell-cycle dependent genes in mammalian cells].
    Ayusawa D
    Tanpakushitsu Kakusan Koso; 1989 Jul; 34(9):1125-34. PubMed ID: 2798918
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of the murine thymidylate kinase gene.
    Liang P; Averboukh L; Zhu W; Haley T; Pardee AB
    Cell Growth Differ; 1995 Oct; 6(10):1333-8. PubMed ID: 8845311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-mRNA processing enhancer (PPE) element increases the expression of an intronless thymidylate synthase gene but does not affect intron-dependent S phase regulation.
    Lee TX; Johnson LF
    J Cell Biochem; 1998 May; 69(2):104-16. PubMed ID: 9548559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive overexpression of DNA binding activity to the distal CCAAT box of human thymidine kinase promoter in human tumor cell lines.
    Chang ZF; Cheng SM
    Cancer Res; 1993 Jul; 53(14):3253-6. PubMed ID: 8324736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protooncogene expression during the cell cycle.
    Kaczmarek L
    Lab Invest; 1986 Apr; 54(4):365-76. PubMed ID: 3007866
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of a set of protein species approximately 40 kDa as high-affinity DNA binding factor(s) to the cell cycle regulatory region of the human thymidine kinase promoter.
    Kim EC; Rawlings SL; Li LJ; Roy B; Lee AS
    Cell Growth Differ; 1996 Dec; 7(12):1741-9. PubMed ID: 8959343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of mutant FM3A murine mammary carcinoma cell strains transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Ayusawa D; Shimizu K; Seno T; Balzarini J; De Clercq E
    Jpn J Cancer Res; 1985 Oct; 76(10):984-8. PubMed ID: 3001011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory mechanisms in the expression of cell cycle dependent genes.
    Rittling SR; Baserga R
    Anticancer Res; 1987; 7(4A):541-52. PubMed ID: 3310845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle regulatory sequences in a hamster histone promoter and their interactions with cellular factors.
    Artishevsky A; Wooden S; Sharma A; Resendez E; Lee AS
    Nature; 1987 Aug 27-Sep 2; 328(6133):823-7. PubMed ID: 3627229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a low dose leucovorin with 5-fluorouracil derivative on colorectal tumors induced with 1,2-dimethylhydrazine in rats.
    Kuwa K; Sakamoto S; Mitamura T; Kudo H; Suzuki S; Fukushima M
    Anticancer Res; 1999; 19(6B):5143-8. PubMed ID: 10697524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of thymidylate synthase gene expression].
    Dabrowska M
    Postepy Biochem; 1998; 44(3):228-36. PubMed ID: 10022042
    [No Abstract]   [Full Text] [Related]  

  • 12. Downregulation of p21/WAF1 expression by thymidylate synthase.
    Kastanos EK; Zajac-Kaye M; Dennis PA; Allegra CJ
    Biochem Biophys Res Commun; 2001 Jul; 285(2):195-200. PubMed ID: 11444825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of an initiator element in the mouse thymidylate synthase promoter alters S phase regulation but has no effect on promoter bidirectionality.
    Kapadia F; Johnson LF
    J Cell Biochem; 2006 Feb; 97(3):599-608. PubMed ID: 16215980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.
    Imaki H; Nakayama K; Delehouzee S; Handa H; Kitagawa M; Kamura T; Nakayama KI
    Cancer Res; 2003 Aug; 63(15):4607-13. PubMed ID: 12907639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The topoisomerase II-inhibitor NC-190 reduces the level of thymidine kinase mRNA in murine tumor cells.
    Samata K; Yamagishi T; Ikeda T; Kuraishi A; Nakaike S; Tanaka M; Kashiwagi K; Igarashi K
    Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):77-87. PubMed ID: 14632316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation-dependent pattern of expression of a dihydrofolate reductase-thymidylate synthase gene from Daucus carota.
    Albani D; Giorgetti L; Pitto L; Luo M; Cantoni RM; Erra Pujada M; Rotino GL; Cella R
    Eur J Histochem; 2005; 49(2):107-15. PubMed ID: 15967738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP-mediated augmentation of thrombomodulin gene expression: cell type-dependent usage of control regions.
    Shirayoshi Y; Imada S; Katayanagi S; Uyeno M; Imada M
    Exp Cell Res; 1993 Sep; 208(1):75-83. PubMed ID: 8395401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.